May - 2021
| Previous Next | Showing Journal 9 of 10 |
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit - The INSPIRATION Randomised TrialJAMA, 2021, 325(16):1620-1630 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
Thromboembolic complications, particularly venous, are common manifestation of COVID-19, with a higher incidence in critically ill patients, estimated at 28%. This has led to uncertainty regarding optimal...